vs

Side-by-side financial comparison of MCGRATH RENTCORP (MGRC) and VERACYTE, INC. (VCYT). Click either name above to swap in a different company.

MCGRATH RENTCORP is the larger business by last-quarter revenue ($256.8M vs $140.6M, roughly 1.8× VERACYTE, INC.). VERACYTE, INC. runs the higher net margin — 29.3% vs 19.4%, a 9.9% gap on every dollar of revenue. On growth, VERACYTE, INC. posted the faster year-over-year revenue change (18.5% vs 5.3%). MCGRATH RENTCORP produced more free cash flow last quarter ($69.8M vs $48.8M). Over the past eight quarters, VERACYTE, INC.'s revenue compounded faster (20.5% CAGR vs 16.9%).

McGrath RentCorp is a leading North American B2B rental provider. It offers relocatable modular office and classroom buildings, portable storage units, and electronic test and measurement equipment, serving construction, education, industrial and technology sector clients across the U.S. and parts of Canada.

Veracyte Inc. is a leading molecular diagnostics company that develops and commercializes proprietary genomic testing solutions for early, accurate detection of cancer and other complex diseases. Its offerings help healthcare providers make better clinical decisions to improve patient outcomes, with core operations in the U.S. and expanding global market presence across key clinical segments.

MGRC vs VCYT — Head-to-Head

Bigger by revenue
MGRC
MGRC
1.8× larger
MGRC
$256.8M
$140.6M
VCYT
Growing faster (revenue YoY)
VCYT
VCYT
+13.2% gap
VCYT
18.5%
5.3%
MGRC
Higher net margin
VCYT
VCYT
9.9% more per $
VCYT
29.3%
19.4%
MGRC
More free cash flow
MGRC
MGRC
$21.0M more FCF
MGRC
$69.8M
$48.8M
VCYT
Faster 2-yr revenue CAGR
VCYT
VCYT
Annualised
VCYT
20.5%
16.9%
MGRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MGRC
MGRC
VCYT
VCYT
Revenue
$256.8M
$140.6M
Net Profit
$49.8M
$41.1M
Gross Margin
50.1%
72.5%
Operating Margin
28.9%
26.4%
Net Margin
19.4%
29.3%
Revenue YoY
5.3%
18.5%
Net Profit YoY
28.0%
704.8%
EPS (diluted)
$2.02
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGRC
MGRC
VCYT
VCYT
Q4 25
$256.8M
$140.6M
Q3 25
$256.4M
$131.9M
Q2 25
$235.6M
$130.2M
Q1 25
$195.4M
$114.5M
Q4 24
$243.7M
$118.6M
Q3 24
$266.8M
$115.9M
Q2 24
$212.6M
$114.4M
Q1 24
$187.8M
$96.8M
Net Profit
MGRC
MGRC
VCYT
VCYT
Q4 25
$49.8M
$41.1M
Q3 25
$42.3M
$19.1M
Q2 25
$36.0M
$-980.0K
Q1 25
$28.2M
$7.0M
Q4 24
$38.9M
$5.1M
Q3 24
$149.3M
$15.2M
Q2 24
$20.6M
$5.7M
Q1 24
$22.8M
$-1.9M
Gross Margin
MGRC
MGRC
VCYT
VCYT
Q4 25
50.1%
72.5%
Q3 25
46.5%
69.2%
Q2 25
47.0%
69.0%
Q1 25
49.3%
69.5%
Q4 24
47.1%
66.4%
Q3 24
46.5%
68.2%
Q2 24
48.6%
68.1%
Q1 24
49.7%
64.5%
Operating Margin
MGRC
MGRC
VCYT
VCYT
Q4 25
28.9%
26.4%
Q3 25
26.0%
17.4%
Q2 25
24.3%
-4.0%
Q1 25
23.3%
2.5%
Q4 24
25.9%
3.5%
Q3 24
28.0%
10.4%
Q2 24
25.6%
4.0%
Q1 24
27.7%
-4.8%
Net Margin
MGRC
MGRC
VCYT
VCYT
Q4 25
19.4%
29.3%
Q3 25
16.5%
14.5%
Q2 25
15.3%
-0.8%
Q1 25
14.4%
6.2%
Q4 24
16.0%
4.3%
Q3 24
56.0%
13.1%
Q2 24
9.7%
5.0%
Q1 24
12.2%
-1.9%
EPS (diluted)
MGRC
MGRC
VCYT
VCYT
Q4 25
$2.02
$0.50
Q3 25
$1.72
$0.24
Q2 25
$1.46
$-0.01
Q1 25
$1.15
$0.09
Q4 24
$1.58
$0.07
Q3 24
$6.08
$0.19
Q2 24
$0.84
$0.07
Q1 24
$0.93
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGRC
MGRC
VCYT
VCYT
Cash + ST InvestmentsLiquidity on hand
$295.0K
$362.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$1.3B
Total Assets
$2.4B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGRC
MGRC
VCYT
VCYT
Q4 25
$295.0K
$362.6M
Q3 25
$7.3M
$315.6M
Q2 25
$1.5M
$219.5M
Q1 25
$3.4M
$186.1M
Q4 24
$807.0K
$239.1M
Q3 24
$4.1M
$274.1M
Q2 24
$9.4M
$235.9M
Q1 24
$1.9M
$209.2M
Stockholders' Equity
MGRC
MGRC
VCYT
VCYT
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.1B
$1.2B
Q3 24
$1.1B
$1.2B
Q2 24
$954.2M
$1.1B
Q1 24
$943.0M
$1.1B
Total Assets
MGRC
MGRC
VCYT
VCYT
Q4 25
$2.4B
$1.4B
Q3 25
$2.4B
$1.4B
Q2 25
$2.3B
$1.3B
Q1 25
$2.2B
$1.3B
Q4 24
$2.3B
$1.3B
Q3 24
$2.3B
$1.3B
Q2 24
$2.3B
$1.2B
Q1 24
$2.3B
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGRC
MGRC
VCYT
VCYT
Operating Cash FlowLast quarter
$80.9M
$52.6M
Free Cash FlowOCF − Capex
$69.8M
$48.8M
FCF MarginFCF / Revenue
27.2%
34.7%
Capex IntensityCapex / Revenue
4.3%
2.7%
Cash ConversionOCF / Net Profit
1.62×
1.28×
TTM Free Cash FlowTrailing 4 quarters
$211.3M
$126.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGRC
MGRC
VCYT
VCYT
Q4 25
$80.9M
$52.6M
Q3 25
$65.1M
$44.8M
Q2 25
$55.8M
$33.6M
Q1 25
$53.9M
$5.4M
Q4 24
$36.8M
$24.5M
Q3 24
$199.0M
$30.0M
Q2 24
$79.2M
$29.6M
Q1 24
$59.4M
$-9.0M
Free Cash Flow
MGRC
MGRC
VCYT
VCYT
Q4 25
$69.8M
$48.8M
Q3 25
$53.5M
$42.0M
Q2 25
$38.2M
$32.3M
Q1 25
$49.9M
$3.5M
Q4 24
$32.6M
$20.4M
Q3 24
$193.0M
$27.7M
Q2 24
$74.4M
$26.8M
Q1 24
$34.1M
$-11.1M
FCF Margin
MGRC
MGRC
VCYT
VCYT
Q4 25
27.2%
34.7%
Q3 25
20.8%
31.8%
Q2 25
16.2%
24.8%
Q1 25
25.5%
3.1%
Q4 24
13.4%
17.2%
Q3 24
72.4%
23.9%
Q2 24
35.0%
23.4%
Q1 24
18.2%
-11.5%
Capex Intensity
MGRC
MGRC
VCYT
VCYT
Q4 25
4.3%
2.7%
Q3 25
4.5%
2.1%
Q2 25
7.5%
1.0%
Q1 25
2.0%
1.6%
Q4 24
1.7%
3.5%
Q3 24
2.2%
1.9%
Q2 24
2.3%
2.4%
Q1 24
13.5%
2.2%
Cash Conversion
MGRC
MGRC
VCYT
VCYT
Q4 25
1.62×
1.28×
Q3 25
1.54×
2.34×
Q2 25
1.55×
Q1 25
1.91×
0.76×
Q4 24
0.94×
4.80×
Q3 24
1.33×
1.98×
Q2 24
3.84×
5.16×
Q1 24
2.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGRC
MGRC

Transferred At Point In Time$73.7M29%
Non Lease Sales$55.4M22%
Trs Ren Telco$40.6M16%
Transferred Over Time$26.0M10%
Portable Storage$23.8M9%
Enviroplex$16.6M6%
Non Lease Rental Related Services$11.1M4%
Other$7.3M3%

VCYT
VCYT

Testing$135.8M97%
Products$3.8M3%
Biopharmaceutical And Other$686.0K0%

Related Comparisons